Healthcare

According to a market report by Lucintel, the future of the pharmaceutical gelatin market looks promising with opportunities in the hard capsule, softgel capsule, tablet, and absorbable hemostat segments. The global pharmaceutical gelatin market is expected to reach an estimated $1.6 billion by 2028 with a CAGR of 5.7% from 2023 to 2028. The major drivers for this market are increasing geriatric population, growing awareness towards consumption of nutrition rich food, and surging demand for pharma gelatin in vaccines, tablets, and other applications.



In this market, type A and type B are the major type segments. Lucintel forecasts that type B pharmaceutical gelatin is expected to witness the higher growth over the forecast period as it is use in various applications across the pharmaceutical industry owing to its low production cost and easy availability of raw materials.



Within this market, softgel capsules are expected to witness the highest growth over the forecast period as they are highly beneficial for low-dose lipid-soluble drugs owing to their capability of being formulated for rapid or slow release.



North America is expected to remain the largest region over the forecast period due to growing demand for prescription and over counter drugs, increasing investment in R&D activities, and presence of highly developed pharmaceutical companies with advanced manufacturing technologies.

Darling Ingredients, Nitta Gelatin, Tessenderlo Group, Gelita AG, and Weishardt are the major suppliers in the global pharmaceutical gelatin market.



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global pharmaceutical gelatin market by type, function, source, application, and region. Lucintel has compiled a comprehensive research report titled “Growth Opportunities in the Global Pharmaceutical Gelatin Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global pharmaceutical gelatin market by type, function, source, application, and region, as follows:

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the pharmaceutical gelatin market by type (type A and type B), function (stabilizing agent, thickening agent, and gelling agent & other function), source (porcine, bovine skin, bovine bone, marine, and poultry), application (hard capsules, softgel capsules, tablets, absorbable hemostats, and other applications), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?

Q.11. What M&A activity did occur in the last five years and how did they impact the industry?